Con: Hypoxic pulmonary vasoconstriction is not a limiting factor of exercise at high altitude

High Altitude Medicine and Biology

Volumn 12, Issue 4, 2011, Pages 313-317

  Anholm, James D ^a   Foster, Gary P ^a  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; DEXAMETHASONE; SILDENAFIL; SITAXSENTAN; TADALAFIL;

ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTERIAL OXYGEN SATURATION; ARTICLE; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; HEART OUTPUT; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG EDEMA; LUNG VASCULAR RESISTANCE; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PRIORITY JOURNAL; SYMPATHETIC TONE; VASODILATATION;

ALTITUDE; ANOXIA; BLOOD PRESSURE; CARDIAC OUTPUT; EXERCISE; HUMANS; HYPERTENSION, PULMONARY; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; PULMONARY CIRCULATION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 84855184298     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2011.1059     Document Type: Article

References (66)

1. Audran M, Gareau R, Matecki S, Durand F, Chenard C, Sicart MT, Marion B, and Bressolle F. (1999). Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 31:639-645. (Pubitemid 29205422)
2. Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, and Bahr R. (2000). Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc 32:1238-1243. (Pubitemid 30482652)
3. Bogaard HJ, Hopkins SR, Yamaya Y, Niizeki K, Ziegler MG, and Wagner PD. (2002). Role of the autonomic nervous system in the reduced maximal cardiac output at altitude. J Appl Physiol 93:271-279. (Pubitemid 34686221)
4. Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, and Saltin B. (2001). Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation 104:1785-1791. (Pubitemid 32963343)
5. Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, and Saltin B. (2003a). Determinants of maximal oxygen uptake in severe acute hypoxia. Am J Physiol Regul Integr Comp Physiol 284:R291-303. (Pubitemid 36120144)
6. Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, and Saltin B. (2003b). Why is VO2 max after altitude acclimatization still reduced despite normalization of arterial O2 content? Am J Physiol Regul Integr Comp Physiol 284:R304-316. (Pubitemid 36120145)
7. Calbet JA, Radegran G, Boushel R, and Saltin B. (2009). On the mechanisms that limit oxygen uptake during exercise in acute and chronic hypoxia: role of muscle mass. J Physiol 587:477-490.
8. Calbet JA, Radegran G, Boushel R, Sondergaard H, Saltin B, and Wagner PD. (2002). Effect of blood haemoglobin concentration on V(O2max) and cardiovascular function in lowlanders acclimatised to 5260m. J Physiol 545:715-728. (Pubitemid 36004399)
9. Cerretelli P. (1976). Limiting factors to oxygen transport on Mount Everest. J Appl Physiol 40:658-667.
10. Dill DB and Adams WC. (1971). Maximal oxygen uptake at sea level and at 3,090m altitude in high school champion runners. J Appl Physiol 30:854-859.
11. Dill DB, Myhre LG, Brown DK, Burrus K, and Gehlsen G. (1967). Work capacity in chronic exposures to altitude. J Appl Physiol 23:555-560.
12. Ekblom B and Berglund B. (1991). Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1:88-93.
13. Eldridge MW, Podolsky A, Richardson RS, Johnson DH, Knight DR, Johnson EC, Hopkins SR, Michimata H, Grassi B, Feiner J, et al. (1996). Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema. J Appl Physiol 81:911-921. (Pubitemid 26303248)
14. Faoro V, Boldingh S, Moreels M, Martinez S, Lamotte M, Unger P, Brimioulle S, Huez S, and Naeije R. (2009). Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia. Chest 135:1215-1222.
15. Faoro V, Lamotte M, Deboeck G, Pavelescu A, Huez S, Guenard H, Martinot JB, and Naeije R. (2007). Effects of sildenafil on exercise capacity in hypoxic normal subjects. High Alt Med Biol 8:155-163. (Pubitemid 47001203)
16. Fischler M, Maggiorini M, Dorschner L, Debrunner J, Bernheim A, Kiencke S, Mairbaurl H, Bloch KE, Naeije R, and Brunner-La Rocca HP. (2009). Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med 180:346-352.
17. Fulco CS, Rock PB, and Cymerman A. (1998). Maximal and submaximal exercise performance at altitude. Aviat Space Environ Med 69:793-801. (Pubitemid 28365793)
18. Ge Y, Bagnall A, Stricklett PK, Strait K, Webb DJ, Kotelevtsev Y, and Kohan DE. (2006). Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol 291:F1274-1280. (Pubitemid 44889187)
19. Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, Seeger W, and Grimminger F. (2004). Sil-denafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: A randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 141:169-177.
20. Groepenhoff H, van der Plas MN, Beloka S, Villafuerte F, Ma-carlupu JL, Overbeek MJ, and Naeije R. (2011). Exercise pathophysiology in patients with chronic mountain sickness [abstract]. Am J Respir Crit Care Med 183:A5750.
21. Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, and Houston CS. (1987). Operation Everest II: Elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 63:521-530. (Pubitemid 17161952)
22. Hsu AR, Barnholt KE, Grundmann NK, Lin JH, McCallum SW, and Friedlander AL. (2006). Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. J Appl Physiol 100:2031-2040. (Pubitemid 43845879)
23. Kollias J, Buskirk ER, Akers RF, Prokop EK, Baker PT, and Pi-con-Reategui E. (1968). Work capacity of long-time residents and newcomers to altitude. J Appl Physiol 24:792-799.
24. Kressler J, Stoutenberg M, Roos BA, Friedlander AL, Perry AC, Signorile JF, and Jacobs KA. (2011). Sildenafil does not improve steady state cardiovascular hemodynamics, peak power, or 15-km time trial cycling performance at simulated moderate or high altitudes in men and women. Eur J Appl Physiol. 111:3031-3040.
25. Lansley KE, Winyard PG, Bailey SJ, Vanhatalo A, Wilkerson DP, Blackwell JR, Gilchrist M, Benjamin N, and Jones AM. (2011). Acute dietary nitrate supplementation improves cycling time trial performance. Med Sci Sports Exerc 43:1125-1131.
26. Leon-Velarde F, Villafuerte FC, and Richalet JP. (2010). Chronic mountain sickness and the heart. Prog Cardiovasc Dis 52:540-549.
27. Lundby C, Boushel R, Robach P, Moller K, Saltin B, and Calbet JA. (2008). During hypoxic exercise some vasoconstriction is needed to match O2 delivery with O2 demand at the micro-circulatory level. J Physiol 586:123-130.
28. Lundby C, Calbet JA, van Hall G, Saltin B, and Sander M. (2004). Pulmonary gas exchange at maximal exercise in Danish low-landers during 8wk of acclimatization to 4,100m and in high-altitude Aymara natives. Am J Physiol Regul Integr Comp Physiol 287:R1202-1208. (Pubitemid 39391066)
29. Lundby C and Damsgaard R. (2006). Exercise performance in hypoxia after novel erythropoiesis stimulating protein treatment. Scand J Med Sci Sports 16:35-40. (Pubitemid 43433303)
30. Lundby C, Sander M, van Hall G, Saltin B, and Calbet JA. (2006). Maximal exercise and muscle oxygen extractionin acclimatizing lowlanders and high altitude natives. J Physiol 573:535-547. (Pubitemid 43878566)
31. Maignan M, Rivera-Ch M, Privat C, Leon-Velarde F, Richalet JP, and Pham I. (2009). Pulmonary pressure and cardiac function in chronic mountain sickness patients. Chest 135:499-504.
32. Moore LG, Cymerman A, Huang SY, McCullough RE, McCul-lough RG, Rock PB, Young A, Young PM, Bloedow D, Weil JV et al. (1986). Propranolol does not impair exercise oxygen uptake in normal men at high altitude. J Appl Physiol 61:1935-1941. (Pubitemid 17196258)
33. Naeije R. (2010). Physiological adaptation of the cardiovascular system to high altitude. Prog Cardiovasc Dis 52:456-466.
34. Naeije R, Huez S, Lamotte M, Retailleau K, Neupane S, Abra-mowicz D, and Faoro V. (2010). Pulmonary artery pressure limits exercise capacity at high altitude. Eur Respir J 36:1049-1055.
35. Olfert IM, Loeckinger A, Treml B, Faulhaber M, Flatz M, Burt-scher M, Truebsbach S, and Kleinsasser A. (2011). Sildenafil and bosentan improve arterial oxygenation during acute hypoxic exercise: A controlled laboratory trial. Wilderness Environ Med 22:211-221.
36. Penaloza D and Arias-Stella J. (2007). The heart and pulmonary circulation at high altitudes: Healthy highlanders and chronic mountain sickness. Circulation 115:1132-1146. (Pubitemid 46673174)
37. Piiper J, Scheid P. (1981). Model for capillary-alveolar equilibration with special reference to O2 uptake in hypoxia. Respir Physiol 46:193-208. (Pubitemid 12248736)
38. Pugh LGCE. (1964). Cardiac output in muscular exercise at 5,800 m (19,000 ft). J Appl Physiol 19:441-447.
39. Pugh LGCE, Gill MB, Lahiri S, Milledge JS, Ward MP, and West JB. (1964). Muscular exercise at great altitudes. J Appl Physiol 19:431-440.
40. Reeves JT, Groves BM, Cymerman A, Sutton JR, Wagner PD, Turkevich D, and Houston CS. (1990). Operation Everest II: Cardiac filling pressures during cycle exercise at sea level. Respir Physiol 80:147-154. (Pubitemid 20209659)
41. Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, and Houston CS. (1987). Operation Everest II: Preservation of cardiac function at extreme altitude. J Appl Physiol 63:531-539. (Pubitemid 17161953)
42. Reeves JT and Leon-Velarde F. (2004). Chronic mountain sickness: Recent studies of the relationship between hemoglobin concentration and oxygen transport. High Alt Med Biol 5:147-155. (Pubitemid 39069616)
43. Ricart A, Maristany J, Fort N, Leal C, Pages T, and Viscor G. (2005). Effects of sildenafil on the human response to acute hypoxia and exercise. High Alt Med Biol 6:43-49. (Pubitemid 40533279)
44. Richalet JP, Gratadour P, Robach P, Pham I, Dechaux M, Jonc-quiert-Latarjet A, Mollard P, Brugniaux J, and Cornolo J. (2005). Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med 171:275-281.
45. Robach P, Calbet JA, Thomsen JJ, Boushel R, Mollard P, Ras-mussen P, and Lundby C. (2008). The ergogenic effect of re-combinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia. PLoS One 3:e2996.
46. Rubin LJ and Naeije R. (2004). Sildenafil for enhanced performance at high altitude? Ann Intern Med 141:233-235. (Pubitemid 39030876)
47. Russell G, Gore CJ, Ashenden MJ, Parisotto R, and Hahn AG. (2002). Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur J Appl Physiol 86:442-449. (Pubitemid 41399062)
48. Saltin B, Grover RF, Blomqvist CG, Hartley LH, and Johnson RL, Jr. (1968). Maximal oxygen uptake and cardiac output after 2 weeks at 4,300m. J Appl Physiol 25:400-409.
49. Sarnquist FH, Schoene RB, Hackett PH, and Townes BD. (1986). Hemodilutionofpolycythemic mountaineers: Effectson exercise and mental function. Aviat Space Environ Med 57:313-317. (Pubitemid 16129596)
50. Schaffartzik W, Barton ED, Poole DC, Tsukimoto K, Hogan MC, Bebout DE, and Wagner PD. (1993). Effect of reduced hemoglobin concentration on leg oxygen uptake during maximal exercise in humans. J Appl Physiol 75:491-498; discussion 489-490. (Pubitemid 23260181)
51. Seheult RD, Ruh K, Foster GP, and Anholm JD. (2009). Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude. Respir Physiol Neurobiol 165:123-130.
52. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, Xu X, Murphy E, Darley-Usmar VM, and Gladwin MT. (2007). Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100:654-661. (Pubitemid 46594879)
53. Siebenmann C, Bloch KE, Lundby C, Nussbamer-Ochsner Y, Schoeb M, and Maggiorini M. (2011). Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559m. High Alt Med Biol 12:169-177.
54. Steinacker JM, Tobias P, Menold E, Reissnecker S, Hohenhaus E, Liu Y, Lehmann M, Bartsch P, and Swenson ER. (1998). Lung diffusing capacity and exercise in subjects with previous high altitude pulmonary oedema. Eur Respir J 11:643-650. (Pubitemid 28194857)
55. Stuber T, Sartori C, Schwab M, Jayet PY, Rimoldi SF, Garcin S, Thalmann S, Spielvogel H, Salmon CS, Villena M, et al. (2010). Exaggerated pulmonary hypertension during mild exercise in chronic mountain sickness. Chest 137:388-392.
56. Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, Malconian MK, Rock PB, Young PM, Walter SD, and Houston CS. (1988). Operation Everest II: Oxygen transport during exercise at extreme simulated altitude. J Appl Physiol 64:1309-1321.
57. Taylor CT and Moncada S. (2010). Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol 30:643-647.
58. Tufts DA, Haas JD, Beard JL, and Spielvogel H. (1985). Distribution of hemoglobin and functional consequences of anemia in adult males at high altitude. Am J Clin Nutr 42:1-11. (Pubitemid 15028517)
59. Wagner PD. (1996). A theoretical analysis of factors determining VO2max at sea level and altitude. Respir Physiol 106:329-343. (Pubitemid 27057712)
60. Wagner PD. (2000a). New ideas on limitations to VO2 max. Exerc Sport Sci Rev 28:10-14.
61. Wagner PD. (2000b). Reduced maximal cardiac output at altitude. Mechanisms and significance. Respir Physiol 120:1-11. (Pubitemid 30154039)
62. Wagner PD. (2010). The physiological basis of reduced VO2max in Operation Everest II. High Alt Med Biol 11:209-215.
63. Wagner PD, Araoz M, Boushel R, Calbet JA, Jessen B, Radegran G, Spielvogel H, Sondegaard H, Wagner H, and Saltin B. (2002). Pulmonary gas exchange and acid-base state at 5,260 m in high-altitude Bolivians and acclimatized lowlanders. J Appl Physiol 92:1393-1400. (Pubitemid 34670891)
64. Wagner PD, Sutton JR, Reeves JT, Cymerman A, Groves BM, and Malconian MK. (1987). Operation Everest II: Pulmonary gas exchange during a simulated ascent of Mt. Everest. J Appl Physiol 63:2348-2359. (Pubitemid 18024857)
65. Winslow RM, Monge CC, Brown EG, Klein NG, Sarnquist F, Winslow NJ, and McKneally SS. (1985). Effects of hemodilu-tion on O2 transport in high-altitude polycythemia. J Appl Physiol 59:1495-1502. (Pubitemid 16197415)
66. Young AJ, Sawka MN, Muza SR, Boushel R, Lyons T, Rock PB, Freund BJ, Waters R, Cymerman A, Pandolf KB et al. (1996). Effects of erythrocyte infusion on VO2max at high altitude. J Appl Physiol 81:252-259. (Pubitemid 26255517)